1.
Variable | Total patients (n=216) | Low albumin group (n=82) albumin < 40 | Normal albumin group (n=127)albumin ≥40 | P | |
Clinical characteristic | |||||
Median follow-up | month (IQR) | 60(48, 60) | 60(24, 60) | 60(60, 60) | 0.038 |
Age | year (IQR) | 60(47, 70.75) | 65.5(56.75.75) | 56(43, 65) | < 0.001 |
Gender | Male (%) | 176(81.5) | 65(79.3) | 104(81.9) | 0.734 |
Female (%) | 40(18.5) | 17(20.7) | 23(18.1) | ||
Smoking status | Yes (%) | 68(31.5) | 56(68.3) | 87(68.5) | 0.974 |
No (%) | 148(68.5) | 26(31.7) | 40(31.5) | ||
Karnofsky score | ≥90 score (%) | 165(76.4) | 59(72) | 102(80.3) | 0.16 |
< 90 score (%) | 51(23.6) | 23(28) | 25(19.7) | ||
ASA score | 1 -2 score (%) | 204(94.4) | 75(91.5) | 122(96.1) | 0.163 |
3-5 score (%) | 12(5.6) | 7(8.5) | 5(3.9) | ||
Pathological characteristic | |||||
Tumor multiplicity | Unifocal (%) | 156(72.2) | 56(68.3) | 93(73.2) | 0.441 |
Multifocal (%) | 60(27.8) | 26(31.7) | 34(26.8) | ||
Pathological T stage | Ta (%) | 182(84.3) | 69(84.1) | 109(85.8) | 0.739 |
T1 (%) | 34(15.7) | 13(15.9) | 18(14.2) | ||
Pathological Grade | Low (%) | 185(85.6) | 69(84.1) | 111(87.4) | 0.506 |
High (%) | 31(14.4) | 13(15.9) | 16(12.6) | ||
Laboratory | |||||
Hemoglobin | g/L | 133.77±21.27 | 127.09±20.29 | 138.1±20.84 | < 0.001 |
Neutrophil count | G/L | 3.80±1.64 | 3.53±1.34 | 3.98±1.79 | 0.029 |
Lymphocyte count | G/L | 2.03±0.68 | 1.89±0.60 | 2.11±0.72 | 0.023 |
Platelet count | G/L | 214.26±54.12 | 211.81±56.10 | 215.84±52.96 | 0.668 |
Albumin | g/L | 40.71±4.31 | 36.91±3.54 | 43.16±2.67 | |
Globulin | g/L | 26.66±16.56 | 28.87±25.82 | 25.24±4.32 | 0.121 |
CKD | 1-2 grade (%) | 156(72.2) | 50(61) | 104(81.9) | 0.001 |
3-5 grade (%) | 51(23.6) | 30(36.6) | 20(15.7) | ||
missing (%) | 9(4.2) | 2(2.4) | 3(2.4) |